The new laboratory plans to determine at least 50 new three-dimensional protein structures of biomedical importance in the next two years.
The SGC, a charity funded with $95 million over three years by GlaxoSmithKline, the government of Ontario, and two Canadian regional research trusts, has been operating since July 2004 and determined 78 novel protein structures in its first year.